- A
- B
- C
- D
- E
- F
- G
- H
- I
- J
- K
- L
- M
- N
- O
- P
- Q
- R
- S
- T
- U
- V
- W
- X
- Y
- Z
Ceritinib Nitroso
Synchemia is a leading Manufacturer in pharmaceutical Nitrosamine compounds. Ceritinib is used to treat metastatic (cancer that has already spread) non-small cell lung cancer in patients who have a certain type of abnormal anaplastic lymphoma kinase (ALK) gene. Your doctor will test for the presence of this gene. Ceritinib is an antineoplastic (cancer) agent.Ceritinib Nitroso is a highly toxic organic compound and a suspected human carcinogen. Handle the material carefully with proper safety measures.
Ceritinib Nitroso CAS NO:NA chemically represented as N-(5-Chloro-2-((2-isopropoxy-5-methyl-4-(piperidin-4-yl)phenyl)amino)pyrimidin-4-yl)-N-(2-(isopropylsulfonyl)phenyl)nitrous amide . Synchemia is the leading manufacturing and exporter of Ceritinib Nitroso.We supply Ceritinib Nitroso with detailed characterization data compliance with regulatory guidelines.
| Product name | Ceritinib Nitroso |
| SRC CAT No | SRC-N014469 |
| CAS No | NA |
| Mol.F. | C28H35ClN6O4S |
| Mol.Wt. | 587.1 |
| Related CAS No. | NA |
| Inv Status | Custom Synthesis |
